MAD MONEY W/ JIM CRAMER - Full Episode

The Dow closed up 56 points today, despite reported threats from N. Korea. Cramer goes Off The Charts to see if AAPL's pain could be the rest of tech's gain. Then, Jim checks up on IMGN, SGEN and ONXX. Is it time to join them in the fight to curb cancer? Plus, leverage ETFs promise more fire power, but wondering why the numbers don't always add up? Cramer opens your eyes to a potential solution.

Today marked the worst day for major averages since Februrary 25th, with the Dow closing down 112 points. Feel like you're down for the count after today's action? Not so fast, Cramer hops in the ring and helps you spot this market's heavy hitters. Then, ready to surge? Jim talks with MHR's CEO about its potential for a turnaround after today's Eagle Ford asses sale. And, the REIT stuff? Cramer goes one-on-one with KIM's top brass to get an unparalleled read on the US consumer and Retail sector. Plus, biotech boom part two - don't miss Cramer's latest additions to his prescription pad.

The Dow finished up 89 points, marking another record highs today. It's happy hour at Mad Money - Cramer brews up a concoction of what's working in this market. Then, trach to treasure? Jim speaks to WM's CEO about the business of waste. Plus, exporting profits - Cramer's exclusive with D's CEO. And, Cramer adds a few more name to his biotech prescription pad - coul it be just what the doctor ordered?

The Dow started the week down 6 points - is it an April fool's market? Cramer's giving his take on today's action. Then, Jim's going over his top orphan drug plays to see if it's just what the doctor ordered. Plus, cream of the crop? Cramer's breaking down the S and P's top performers of the first quarter. And, infrastructure showdow - Jim's comparing AWK to ENB.

Mad Money for March 28, 2013

The Dow has closed down two of the past three trading days, ending 33 points lower today. While worries about Europe may have rattled today's market, Cramer's helping you map out your next move. Then, looking for the next big medical breakthrough, Jim's telling you whether BIIB may be worth examining. And, time to suit up in some PVH? Cramer's talking with its CEO to see if it has what it takes to stay on trend after earnings.

The Dow set a new all-time high today, rising 112 points. Cramer puts the positive action into perspective. Then, have the rough waters calmed for the dry bulk shippers? Jim goes off the charts with DSX. Plus, the biotech boom - Cramer tells you why GILD could be ready to roar. Next, time to make room for AHT in your portfoilio? And, Jim weighs in on all the DELL action on Wall Street.

The Dow started the week down 64 points, as initial optimism over a deal to keep Cyprus afloat faded. Looking for your next move in this market? Cramer's got answers. Then, Jim's schooling you on everything you need to know about Pinnacle Foods upcoming IPO. Plus, looking for the next medical breakthrough? Cramer's highlighting CELG's potential for profits. And, Jim's telling you if AWK could sink or swim in this market.

The Dow closed up 91 points, finishing the week on a positive note. Tonight, Cramer goes over next week's big events in his Game Plan. Then, slick situation? Jim tells you which oil and gas company could drill profits for your portfolio. Plus, Cramer's shinning some light on the sunny side of CPWR's cloud offerings to see if it could be your ticket to returns in 2013.

The Dow closed down 90 points today. As business moves around more data than ever, could QLIK's connection to social and mobile put you in touch with a winner? Then, some high profile companies have recently had big changes at the top. But, how do you know which to worry about and which are much to do about nothing?

Stocks jumped after today's Fed statement, but faded into the close, with the Dow ending 56 points higher. In Bernanke we trust? Cramer breaks down today's market action. Then, from the breakfast table and beyond? Jim goes one-on-one with GIS's CEO fresh off earnings to see if there could be more to chew on. And, are profits in the pipeline for SN? Cramer's drilling down on the company's potential with its CEO after its recent asset purchase from HES. Plus, Jim thinks an investment in the rail sector could be ready to pick up speed - find out which stock is his favorite in today's round of Oligopoly.

The Dow closed up 4 points today, erasing the day's early losses. Reading between the lines - Cramer tells you which headlines really matter. Then, ahead of tomorrow's Fed meeting - Jim breaks down the importance of bonds in gauging this market. Plus, Cramer tells you which rental car company could be geared up for profits. And, could NPSP put your portfolio in recovery mode? Cramer chats with the CEO after today's monster rally.

The Dow started the week down 62 points due to the unusual terms of the EU bailout of Cyprus - worth the worry? Cramer's telling you what to make of the news across the pond. Then, the monopoly of many? Jim's getting his game on with the airline sector. And, Cramer's comparing HAIN and BNNY in an organic stock showdown. Plus, time to play defense with KMB? Jim's giving his take.

The Dow closed down 25 points today, ending its longest winning streak in 17 years. Tonight, Cramer goes over next week's earnings in his Game Plan. Then, ridiculous returns? Jim celebrates some of the market's top performers of the past 8 years on a special 8th anniversary episode. And, shares of MRK have recently been lagging, but Cramer's checking its vitals to find out if its prognosis could soon improve.

The Dow closed up for the 10th day in a row, rising 84 points as the S and P closes in on its all-time high. What the fed giveth, the fed can taketh away? Then, hunting for a play of the red hot housing sector? Find out if it's time to move in the RDN. Plus, could CCH help you go from a coin purse to a money clip? And, can N help send your portolio to the clouds? Cramer decides.